AKT1 and minimally invasive lung adenocarcinoma: In our study, we found that BAC increased total serum NO, and activated Akt/eNOS pathway in BAC-treated SHRs, while the level of TNF-α and IL-6, expression of COX-2, and phosphorylation of IKB-α decreased.